The HepaRG cell line is suitable for bioartificial liver application.

Ruurdtje Hoekstra1, Geert A A Nibourg, Tessa V van der Hoeven

  • 1Surgical Laboratory, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. r.hoekstra@amc.uva.nl

Summary

HepaRG cells demonstrate robust metabolic and synthetic functions without dimethyl sulfoxide (DMSO), while drug metabolism is enhanced with DMSO. Combining both conditions optimizes hepatic functionality for bioartificial liver applications.